ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: A study by Cengiz et al. involving 69 patients with NAFLD diagnosed by liver biopsy and 69 healthy controls showed that the circulating ANGPTL8 in patients with NAFLD was significantly lower than that in healthy subjects, and the higher the degree of liver fibrosis, the lower the ANGPTL8 level [47].